TheraRadar
← Back
Data updated: Mar 29, 2026

FOSUN PHARMA

OncologyCardiovascularNeurology
Generics

FOSUN PHARMA is a generic drug manufacturer focused on Oncology, Cardiovascular, Neurology.

1959
Since
24
Drugs
-
Trials
479
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
PROPRANOLOL HYDROCHLORIDE 2026-01-27
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 41%
1 drugs Phase 3: 1 Phase 2: 1 Phase 1: 5
Cardiovascular 15%
1 drugs
Neurology 15%
1 drugs
Infectious Disease 15%
1 drugs
Dermatology 15%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular